Holen Sie sich die Stockscreener-App
4.38
3.74%
-0.17
Vorhandelsmarkt:
4.34
-0.04
-0.91%
Schlusskurs vom Vortag:
$4.55
Offen:
$4.58
24-Stunden-Volumen:
231.95K
Relative Volume:
0.16
Marktkapitalisierung:
$8.23M
Einnahmen:
$15.66M
Nettoeinkommen (Verlust:
$5.83M
KGV:
-0.1833
EPS:
-23.8939
Netto-Cashflow:
$466.20K
1W Leistung:
-3.31%
1M Leistung:
-77.49%
6M Leistung:
-13.35%
1J Leistung:
+0.00%
1-Tages-Spanne:
$4.33
$4.60
1-Wochen-Bereich:
$4.33
$5.09
52-Wochen-Spanne:
$2.90
$21.40
Neuphoria Therapeutics Inc Stock (NEUP) Company Profile
Firmenname
Neuphoria Therapeutics Inc
Sektor
Branche
Telefon
781-439-5551
Adresse
100 SUMMIT DR, BURLINGTON
Vergleichen Sie NEUP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NEUP
Neuphoria Therapeutics Inc
|
4.38 | 10.73M | 15.66M | 5.83M | 466.20K | -23.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Neuphoria Therapeutics Inc Stock (NEUP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-09-28 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2023-09-28 | Bestätigt | Maxim Group | Buy |
| 2022-01-10 | Eingeleitet | Berenberg | Buy |
| 2022-01-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-01-10 | Eingeleitet | Evercore ISI | Outperform |
| 2022-01-10 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Neuphoria Therapeutics Inc Aktie (NEUP) Neueste Nachrichten
Is Neuphoria Therapeutics Inc. stock attractive after correctionRate Cut & Fast Exit and Entry Trade Guides - newser.com
Can Neuphoria Therapeutics Inc. stock maintain operating marginsJuly 2025 EndofMonth & Safe Capital Growth Tips - newser.com
Will Neuphoria Therapeutics Inc. stock attract more institutional investorsEarnings Trend Report & Stepwise Trade Execution Plans - newser.com
What indicators show strength in Neuphoria Therapeutics Inc.2025 AllTime Highs & Consistent Return Strategy Ideas - newser.com
Can Neuphoria Therapeutics Inc. stock hit analyst price targets2025 Volatility Report & AI Driven Stock Movement Reports - newser.com
What valuation multiples suggest for Neuphoria Therapeutics Inc. stockJuly 2025 Volume & Free Technical Confirmation Trade Alerts - newser.com
How to read the order book for Neuphoria Therapeutics Inc.July 2025 Gainers & Weekly High Conviction Trade Ideas - newser.com
What does recent volatility data suggest for Neuphoria Therapeutics Inc.2025 Investor Takeaways & AI Driven Price Forecasts - newser.com
What Wall Street predicts for Neuphoria Therapeutics Inc. stock priceJuly 2025 Decliners & Breakout Confirmation Alerts - newser.com
Why hedge funds are buying Neuphoria Therapeutics Inc. stockQuarterly Trade Review & Risk Controlled Daily Plans - newser.com
Will Neuphoria Therapeutics Inc. stock deliver shareholder valueTrade Entry Report & Fast Entry High Yield Stock Tips - newser.com
Can Neuphoria Therapeutics Inc. stock rebound after recent weaknessJuly 2025 Weekly Recap & Community Supported Trade Ideas - newser.com
How Neuphoria Therapeutics Inc. stock performs in interest rate cyclesJuly 2025 Earnings & Fast Moving Stock Watchlists - newser.com
Will Neuphoria Therapeutics Inc. stock keep outperforming rivalsEntry Point & Free AI Powered Buy and Sell Recommendations - newser.com
Neuphoria Therapeutics Inc.’s volatility index tracking explainedWeekly Profit Analysis & Low Risk Profit Maximizing Plans - newser.com
Can Neuphoria Therapeutics Inc. stock sustain institutional interestStop Loss & Verified Short-Term Trading Plans - newser.com
Why analysts upgrade Neuphoria Therapeutics Inc. stockShare Buyback & Stock Portfolio Risk Management - newser.com
Using AI based signals to follow Neuphoria Therapeutics Inc.July 2025 Decliners & Low Risk High Reward Ideas - newser.com
Is Neuphoria Therapeutics Inc. showing signs of accumulationQuarterly Earnings Report & Expert Approved Momentum Trade Ideas - newser.com
Neuphoria Therapeutics Inc. (NEUP) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
What drives Neuphoria Therapeutics Inc stock priceEvening Star Patterns & Big Gains Small Budget - earlytimes.in
Why Did NEUP Stock Surge 64% Today? - MSN
Is Neuphoria Therapeutics Inc. (NASDAQ:NEUP) Worth US$4.4 Based On Its Intrinsic Value? - Yahoo Finance
Automated trading signals detected on Neuphoria Therapeutics Inc.Earnings Recap Report & Daily Market Momentum Tracking - newser.com
Best Biotech Stocks To ResearchOctober 26th - MarketBeat
Finanzdaten der Neuphoria Therapeutics Inc-Aktie (NEUP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):